Breaking News

Theorem Promotes Veteran Researcher

September 10, 2013

Lake to lead respiratory biopharma franchise

Phil Lake has been appointed executive director of biopharmaceutical development, respiratory, at Theorem Clinical Research. Mr. Lake will be responsible for senior oversight on major projects as well as building the company’s respiratory business globally.
 
Mr. Lake joined Theorem as senior director of project management in 2012. He has held positions including managing director of Springfield Clinical Consulting, executive director of project management in Europe for Covance and as senior clinical research manager for GlaxoSmithKline in London. He has significant therapeutic experience in respiratory disorders, including numerous COPD and asthma studies.
 
“Phil Lake has been a tremendous asset to our European operations, and I am confident he has the contacts and experience to take our biopharmaceuticals division to the next level,” said Theorem president and chief executive officer, John Potthoff.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.